Welcome to LookChem.com Sign In|Join Free
  • or
Methanesulfonic acid, trifluoro-, 2-acetyl-6-nitro-4-(phenylmethoxy)phenyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

861841-93-2

Post Buying Request

861841-93-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

861841-93-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 861841-93-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,1,8,4 and 1 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 861841-93:
(8*8)+(7*6)+(6*1)+(5*8)+(4*4)+(3*1)+(2*9)+(1*3)=192
192 % 10 = 2
So 861841-93-2 is a valid CAS Registry Number.

861841-93-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name trifluoromethansulfonic acid 2-acetyl-4-benzyloxy-6-nitro-phenyl ester

1.2 Other means of identification

Product number -
Other names trifluormethansulfonic acid 2-acetyl-4-benzyloxy-6-nitro-phenyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:861841-93-2 SDS

861841-93-2Relevant academic research and scientific papers

Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient

-

Page/Page column 40, (2010/11/25)

Disclosed are medicament combinations which contain in addition to one or more, preferably one, compound of general formula 1 wherein the groups X, Ra, Rb, R1, R1′, R2, R2′, R2″,

Medicament Combinations for the Treatment of Respiratory Diseases

-

Page/Page column 34, (2010/11/28)

The present invention relates to new medicament combinations which contain in addition to one or more, preferably one compound of general formula 1 wherein A, B, R1, X, n and m may have the meanings given in the claims and in the specification, at least one other active substance 2, processes for preparing them and their use as pharmaceutical compositions.

New betamimetics for the treatment of respiratory complaints

-

Page/Page column 11, (2010/10/20)

The present invention relates to compounds of formula 1 wherein the groups n, m, B, X and R1 may have the meanings given in the claims and specification, processes for preparing them and their use as pharmaceutical compositions, particularly as pharmaceutical compositions for the treatment of respiratory complaints.

New long acting beta-2-agonists and their use as medicaments

-

Page/Page column 14, (2008/06/13)

The present invention relates to compounds of formula 1 wherein the groups X, Ra, Rb, R1, R1′, R2, R2′, R2″, R2′″, V and n may have the meanings given in the claims an

NOVEL LONG-WORKING BETA-2-AGONISTS AND USE THEREOF AS MEDICAMENTS

-

Page/Page column 29-30, (2008/06/13)

The invention relates to compounds of formula (1), wherein groups X, Ra, Rb, R1, R1', R2, R2', R2'', R2''', V and n can have the meanings as cited in the claims and in

HYDROXY-SUBSTITUTED BENZO-CONDENSED HETEROCYCLES FOR USE AS BETA AGONISTS IN THE TREATMENT OF RESPIRATORY DISEASES

-

Page/Page column 26, (2010/02/14)

The invention relates to the compounds of general formula (1), wherein the groups n, A, B, R1, R2 and R3 are defined as in the claims and in the description, and to methods for producing the same. The invention also relates to the use of these compounds as drugs, especially as drugs for use in the treatment of respiratory diseases.

Beta agonists for the treatment of respiratory diseases

-

Page/Page column 11, (2010/02/15)

The present invention relates to compounds of general formula 1 wherein the groups n, A, B, R1, R2 and R3 may have the meanings given in the claims and in the specification, processes for preparing them, and their use as pharmaceutical compositions, particularly as pharmaceutical compositions for the treatment of respiratory complaints.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 861841-93-2